New Health Investment Trend: Splash Beverage Group Makes Strategic Investment in Cannabinoid Biopharmaceutical Platform Avicanna
Splash Beverage Group announced a CAD 300,000 strategic investment in Avicanna, a leading cannabinoid biopharmaceutical company, advancing its transformation into a cannabinoid healthcare platform. Avicanna excels in clinical research, patient care, and pharmaceutical product development within the cannabinoid medical field.